SHIVALIK RASAYAN PHARMACEUTICALS COMPNY LONGTERM RANGE BREKOUT.

٢ أغسطس ٢٠٢٠

SHIVALIK RASAYAN ONE OF THE API MANUFACTURE NOW A DAYS ALL PHARAM STOCK AS WELL AS PHARMA INDEX LOOKS BULLISH AND GOVERNMENT ALSO INCREASED IMPORT DUTY ON API. WHICH WILL BOOST DOMESTIC PRODUCTION COMPANY FUNDAMENTAL ALSO IN LINE I PERSONALLY EXPECT THIS SHARE CAN TOUCH 600,650,700,800 + BEST BUY BETWEEN 450 TO 400 SUPPORT 250.